Karin Andersen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Karin Andersen has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Hanne Kobberø
Department of Urology, Odense University Hospital, Odense, Denmark
2 shared publications - Mads Hvid Poulsen
Department for Urology, Esbjerg and Grindsted Hospital, University Hospital of Southern Denmark, 6700 Esbjerg, Denmark
2 shared publications - Torben Brøchner Pedersen
Department of Urology, Odense University Hospital, Odense, Denmark
2 shared publications Charlotte Graugaard-Jensen
B Department of Urology , University Hospital of Aarhus , Aarhus , Denmark
1 shared publication- Dorte Kildegaard
A Department of Sports Science and Clinical Biomechanics , University of Southern Denmark , Odense , Denmark
1 shared publication Janni Søvsø Hjelmager
Research Unit of Clinical Microbiology University of Southern Denmark Odense Denmark
1 shared publication
Latest Publications
- 4 March 2026
- Published by Wiley in BJU International
- Vol. 137 (5) , 924
Response to: Bridging research and patient experience in chronic urinary tract infection
- 4 March 2026
- Published by Wiley in BJU International
- Vol. 137 (5) , 924
Response to: Bridging research and patient experience in chronic urinary tract infection
- Open Access
- 20 July 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (8) , 2169-2177
Switching from intermittent catheterization with single‐use catheter to a reusable catheter has a negative impact on quality of life
Purpose: It has been proposed that reusable catheters are more cost effective and environmentally sustainable than single‐use catheters intended for intermittent catheterization (IC). However, the aspect of individuals' well‐being and preference for catheter type is not considered. In this study, we investigated the impact on individuals' health‐related quality of life (HR‐QoL) when testing a reusable catheter.Materials and Methods: The study was an open‐labeled, single‐arm, multicenter investigation with a treatment period of 28 days. Forty subjects using single‐use hydrophilic catheters were accustomed to a reusable catheter for managing IC. HR‐QoL was evaluated by the Intermittent‐Self Catheterization Questionnaire (ISC‐Q). Additionally, satisfaction was evaluated by the Intermittent Catheterization Satisfaction Questionnaire (InCaSa‐Q). The difference in total score was analyzed using a mixed linear model. Furthermore, preference for IC (single‐use vs. reusable) was assessed and microbial evaluation of the catheters was performed.Results: The total ISC‐Q score measuring HR‐QoL decreased significantly by 28% (p < 0.001). Two of the four subdomains (ease‐of‐use and discreetness) also decreased significantly (p < 0.001). The total InCaSa‐score and all four subdomains evaluating satisfaction decreased significantly (p < 0.005). The primary study results were supported by the fact that 90.9% of subjects preferred to use a single‐use catheter for IC. Furthermore, 50% of reusable catheters were contaminated with bacteria.Conclusion: Switching from single‐use to reusable IC resulted in a significant decrease in HR‐QoL and satisfaction. Moreover, the vast majority preferred the single‐use catheter due to handling and convenience. The users' rights to their preferred bladder management method should be acknowledged.
- 20 July 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (8) , 2169-2177
Open AccessSwitching from intermittent catheterization with single‐use catheter to a reusable catheter has a negative impact on quality of life
Purpose: It has been proposed that reusable catheters are more cost effective and environmentally sustainable than single‐use catheters intended for intermittent catheterization (IC). However, the aspect of individuals' well‐being and preference for catheter type is not considered. In this study, we investigated the impact on individuals' health‐related quality of life (HR‐QoL) when testing a reusable catheter.Materials and Methods: The study was an open‐labeled, single‐arm, multicenter investigation with a treatment period of 28 days. Forty subjects using single‐use hydrophilic catheters were accustomed to a reusable catheter for managing IC. HR‐QoL was evaluated by the Intermittent‐Self Catheterization Questionnaire (ISC‐Q). Additionally, satisfaction was evaluated by the Intermittent Catheterization Satisfaction Questionnaire (InCaSa‐Q). The difference in total score was analyzed using a mixed linear model. Furthermore, preference for IC (single‐use vs. reusable) was assessed and microbial evaluation of the catheters was performed.Results: The total ISC‐Q score measuring HR‐QoL decreased significantly by 28% (p < 0.001). Two of the four subdomains (ease‐of‐use and discreetness) also decreased significantly (p < 0.001). The total InCaSa‐score and all four subdomains evaluating satisfaction decreased significantly (p < 0.005). The primary study results were supported by the fact that 90.9% of subjects preferred to use a single‐use catheter for IC. Furthermore, 50% of reusable catheters were contaminated with bacteria.Conclusion: Switching from single‐use to reusable IC resulted in a significant decrease in HR‐QoL and satisfaction. Moreover, the vast majority preferred the single‐use catheter due to handling and convenience. The users' rights to their preferred bladder management method should be acknowledged.
- 9 September 2022
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 56 (5-6) , 404-411
Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital
Sacral neuromodulation (SNM) is a well-established treatment modality for idiopathic overactive bladder and urgency incontinence, idiopathic fecal incontinence and non-obstructive urinary retention...
- 9 September 2022
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 56 (5-6) , 404-411
Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital
Sacral neuromodulation (SNM) is a well-established treatment modality for idiopathic overactive bladder and urgency incontinence, idiopathic fecal incontinence and non-obstructive urinary retention...
- 26 February 2021
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 55 (2) , 169-176
Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience
Overactive bladder (OAB) affects hundreds of millions of people worldwide and has significant detrimental effects on quality-of-life. Percutaneous tibial nerve stimulation (PTNS) is endorsed in the...
- 26 February 2021
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 55 (2) , 169-176
Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience
Overactive bladder (OAB) affects hundreds of millions of people worldwide and has significant detrimental effects on quality-of-life. Percutaneous tibial nerve stimulation (PTNS) is endorsed in the...
- 2 January 2019
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 53 (1) , 62-68
Danish version of the National Institutes of Health–Chronic Prostatitis Symptom Index (NIH-CPSI) questionnaire: a linguistic translation, cross-cultural adaptation and test–re-test reliability study
Objective: To translate and cross-culturally adapt the National Institutes of Health–Chronic Prostatitis Symptom Index (NIH-CPSI) into Danish and assess the reliability of the translated version. Methods: The NIH-CPSI was translated into Danish by a formalized translation procedure. Study participants suffering from Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) were recruited from a CP/CPPS newsletter email-list. The translated questionnaire was tested for face validity by interviewing men (n = 7) suffering from CP/CPPS. Relative reliability (interclass correlations coefficient, ICC) and absolute reliability (minimal detectable change, MDC; and standard error of measurement, SEM) were assessed on an electronic version of the Danish NIH-CPSI, including a general response assessment of symptom stability at the second assessment. Results: One hundred and twenty-nine men volunteered for the test–re-test study, 43 did not fit the eligibility criteria or had incomplete tests and 27 were excluded due to symptom changes between test and re-test, leaving 59 participants for the reliability study. The relative reliability for the total NIH-CPSI score was found to be an excellent ICC of 0.93 (95% CI = 0.91–0.96). The absolute reliability for the total NIH-CPSI score revealed an MDC of 5.0 and a SEM of 1.8, corresponding to 12% and 4%, respectively, of the maximal obtainable NIH-CPSI score. Conclusion: The NIH-CPSI questionnaire was successfully translated and cross-culturally adapted into a Danish version. An electronic version of the Danish NIH-CPSI showed excellent reliability. The questionnaire is suitable for use as an outcome measure in research studies and may also be a useful tool in the clinical setting.
- 2 January 2019
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 53 (1) , 62-68
Danish version of the National Institutes of Health–Chronic Prostatitis Symptom Index (NIH-CPSI) questionnaire: a linguistic translation, cross-cultural adaptation and test–re-test reliability study
Objective: To translate and cross-culturally adapt the National Institutes of Health–Chronic Prostatitis Symptom Index (NIH-CPSI) into Danish and assess the reliability of the translated version. Methods: The NIH-CPSI was translated into Danish by a formalized translation procedure. Study participants suffering from Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) were recruited from a CP/CPPS newsletter email-list. The translated questionnaire was tested for face validity by interviewing men (n = 7) suffering from CP/CPPS. Relative reliability (interclass correlations coefficient, ICC) and absolute reliability (minimal detectable change, MDC; and standard error of measurement, SEM) were assessed on an electronic version of the Danish NIH-CPSI, including a general response assessment of symptom stability at the second assessment. Results: One hundred and twenty-nine men volunteered for the test–re-test study, 43 did not fit the eligibility criteria or had incomplete tests and 27 were excluded due to symptom changes between test and re-test, leaving 59 participants for the reliability study. The relative reliability for the total NIH-CPSI score was found to be an excellent ICC of 0.93 (95% CI = 0.91–0.96). The absolute reliability for the total NIH-CPSI score revealed an MDC of 5.0 and a SEM of 1.8, corresponding to 12% and 4%, respectively, of the maximal obtainable NIH-CPSI score. Conclusion: The NIH-CPSI questionnaire was successfully translated and cross-culturally adapted into a Danish version. An electronic version of the Danish NIH-CPSI showed excellent reliability. The questionnaire is suitable for use as an outcome measure in research studies and may also be a useful tool in the clinical setting.